|
|
"EMMA": Emerging Markets for Microfluidic ApplicationsPublished by: Yole Developpement Published: Jun. 1, 2007 - 252 Pages Table of Contents
AbstractMicrofluidics is becoming a key technology integrated in most of Life Science companies’ development roadmap.Drug discovery remains today the first microfluidics market. Microfluidics key advantage is to enable higher analysis throughput while decreasing analysis time and cost. Firstly used at the system level for liquid handling, microfluidics technology is also successfully integrated in cartridges for research applications. Commercialised by SME and big instrumentation companies, microfluidics products are bound to be part of the gold standard technologies used in research applications. The microfluidics market for research applications will steadily grow in the 5 coming years, but the double digit growth will come from the diagnostic market. Indeed microfluidics has a strong competitive advantage in this market enabling analysis automation and decentralisation, but also in facilitating the molecular diagnostic emergence and success. Microfluidics components for diagnostic are expected to reach €1b market value in 2011 with a Total Accessible Market of about 5b€. If microfluidics proof of concept is validated now, no real standard has been defined yet. Dedicated to research applications, microfluidics products are rather produced in low volume. The microfluidics penetration in the diagnostic market will require the technology validation from a manufacturability point of view. Only the technologies fitting with the diagnostic market cost and regulation pressure will success. Such standardisation will lead to a structuration of the industrial food chain. New players are entering the field. Some microfluidics companies adapt their business model to the market evolution. Mergers and acquisitions are also increasing. Most of diagnostic companies have positioned microfluidics in their development roadmap as a key technology to support their growth strategy. Indeed microfluidics is clearly identified as an enabling technology to support the development of the point of care and the molecular biology markets. All ingredients are gathered for success:
2 - Microfluidics provides the expected technical solutions required in the diagnostic market evolution 3 - Innovative high tech companies are entering the diagnostic field. They will participate to the market dynamism in facilitating convergence of technologies like microfluidics and biomarkers. 3M, Bartels mikrotechnik, Boehringer Ingelheim microParts, Caliper LS, Carclo Technical Plastics, Diagnoswiss, Dolomite, Dyconex, eGene, Eksigent Technologies, Epigem, Fluidigm, Fluigent, Genesystems, Gyros, IMM, IQ micro, Micralyne Microfluidics chip shop, Micronics, Micronit microfluidics, Microplumbers, Nanogen, Osmotech, Rain Dance, SpinX, ThinXXS, Wasatch microfluidics, Weidmann Plastics, Wilden AG… Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||